Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-06-06 Purchase | 2023-06-08 4:34 pm | Aprea Therapeutics Inc. | APRE | Seizinger Bernd R. Director | 10,097 | $3.6602 | $36,957 | 26,325 (Direct) | View |
| 2022-05-18 Purchase | 2022-05-19 4:31 pm | Aprea Therapeutics Inc. | APRE | Seizinger Bernd R. Director | 50,000 | $0.71 | $35,500 | 318,580 (Direct) | View |
| 2022-05-18 Purchase | 2022-05-19 4:30 pm | Aprea Therapeutics Inc. | APRE | SCHADE CHRISTIAN S Chairman & CEO | 37,500 | $0.6433 | $24,124 | 303,616 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-08-23 Conversion | 2023-08-24 9:52 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Pamukcu Rifat Director | 353,265 | $0 | 19,464 (Direct) | View |
| 2023-08-23 Option Award | 2023-08-24 9:52 pm | N/A 2033-08-23 | Aprea Therapeutics Inc. | APRE | Pamukcu Rifat Director | 2,500 | $0 | 19,464 (Direct) | View |
| 2023-08-23 Option Award | 2023-08-24 9:51 pm | N/A 2033-08-23 | Aprea Therapeutics Inc. | APRE | Grissinger Michael Director | 2,500 | $0 | 2,799 (Direct) | View |
| 2023-08-23 Option Award | 2023-08-24 9:51 pm | N/A 2033-08-23 | Aprea Therapeutics Inc. | APRE | HENNEMAN JOHN B III Director | 2,500 | $0 | 3,279 (Direct) | View |
| 2023-08-23 Option Award | 2023-08-24 9:50 pm | N/A 2033-08-23 | Aprea Therapeutics Inc. | APRE | Peters Richard Director | 2,500 | $0 | 3,029 (Direct) | View |
| 2022-08-23 Conversion | 2023-08-24 9:50 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Duey Marc Director | 4,423,430 | $0 | 211,480 (Direct) | View |
| 2023-08-23 Option Award | 2023-08-24 9:50 pm | N/A 2033-08-23 | Aprea Therapeutics Inc. | APRE | Duey Marc Director | 2,500 | $0 | 211,480 (Direct) | View |
| 2023-08-23 Option Award | 2023-08-24 9:48 pm | N/A 2033-08-23 | Aprea Therapeutics Inc. | APRE | Seizinger Bernd R. Director | 2,500 | $0 | 28,825 (Direct) | View |
| 2023-08-23 Option Award | 2023-08-24 9:47 pm | N/A 2033-08-23 | Aprea Therapeutics Inc. | APRE | BIZZARI JEAN-PIERRE Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2023-05-05 Option Award | 2023-05-08 5:17 pm | N/A 2033-05-05 | Aprea Therapeutics Inc. | APRE | Gruia Gabriela Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2022-08-23 Conversion | 2023-03-13 6:30 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Gilad Oren President, CEO | 6,649,610 | $0 | 338,770 (Direct) | View |
| 2023-03-09 Option Award | 2023-03-13 6:30 pm | N/A 2033-03-09 | Aprea Therapeutics Inc. | APRE | Gilad Oren President, CEO | 20,000 | $0 | 338,770 (Direct) | View |
| 2023-02-27 Option Award | 2023-02-27 6:37 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | 1,000 | $5.25 | 14,493 (Direct) | View |
| 2023-01-30 Option Award | 2023-01-30 5:21 pm | N/A 2033-01-30 | Aprea Therapeutics Inc. | APRE | Hamill John P. SrVP/CFO/Prin. Fin&Acctg. Off | 809,637 | $0 | 809,637 (Direct) | View |
| 2022-07-28 Option Award | 2022-08-01 5:06 pm | N/A 2032-07-28 | Aprea Therapeutics Inc. | APRE | Seizinger Bernd R. Director | 35,570 | $0 | 354,150 (Direct) | View |
| 2022-07-28 Option Award | 2022-08-01 5:06 pm | N/A 2032-07-28 | Aprea Therapeutics Inc. | APRE | SCHADE CHRISTIAN S Director | 80,000 | $0 | 317,846 (Direct) | View |
| 2022-07-28 Option Award | 2022-08-01 5:05 pm | N/A 2032-07-28 | Aprea Therapeutics Inc. | APRE | Peters Richard Director | 35,570 | $0 | 40,180 (Direct) | View |
| 2022-07-28 Option Award | 2022-08-01 5:04 pm | N/A 2032-07-28 | Aprea Therapeutics Inc. | APRE | Pamukcu Rifat Director | 35,570 | $0 | 47,736 (Direct) | View |
| 2022-07-28 Option Award | 2022-08-01 5:04 pm | N/A 2032-07-28 | Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan SVP, Chief Operating Officer | 60,000 | $0 | 81,462 (Direct) | View |
| 2022-07-28 Option Award | 2022-08-01 5:03 pm | N/A 2032-07-28 | Aprea Therapeutics Inc. | APRE | HENNEMAN JOHN B III Director | 35,570 | $0 | 45,180 (Direct) | View |
| 2022-07-28 Option Award | 2022-08-01 5:02 pm | N/A 2032-07-28 | Aprea Therapeutics Inc. | APRE | Grissinger Michael Director | 35,570 | $0 | 35,570 (Direct) | View |
| 2022-07-28 Option Award | 2022-08-01 5:01 pm | N/A 2032-07-28 | Aprea Therapeutics Inc. | APRE | Gilad Oren President, CEO | 250,000 | $0 | 479,014 (Direct) | View |
| 2022-07-28 Option Award | 2022-08-01 5:00 pm | N/A 2032-07-28 | Aprea Therapeutics Inc. | APRE | Duey Marc Director | 35,570 | $0 | 187,913 (Direct) | View |
| 2022-07-28 Option Award | 2022-08-01 5:00 pm | N/A 2032-07-28 | Aprea Therapeutics Inc. | APRE | Coiante Scott M SVP, Chief Financial Officer | 150,000 | $0 | 234,265 (Direct) | View |
| 2022-06-03 Tax Withholding | 2022-06-07 5:05 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | SCHADE CHRISTIAN S Chairman & CEO | 65,770 | $0.805 | 237,846 (Direct) | View |
| 2022-06-03 Tax Withholding | 2022-06-07 5:02 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Coiante Scott M SVP, Chief Financial Officer | 35,284 | $0.805 | 84,265 (Direct) | View |
| 2022-06-03 Tax Withholding | 2022-06-07 5:01 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan SVP, Chief Operating Officer | 8,390 | $0.805 | 21,462 (Direct) | View |
| 2022-06-03 Tax Withholding | 2022-06-07 5:00 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Attar Eyal C. SVP, Chief Medical Officer | 32,667 | $0.805 | 57,564 (Direct) | View |
Ownership | 2022-05-26 4:15 pm | 2022-05-16 2029-01-19 | Aprea Therapeutics Inc. | APRE | Grissinger Michael Director | 0 | $0 | 72,638 (Direct) | View |
Ownership | 2022-05-26 4:15 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Pamukcu Rifat Director | 0 | $0 | 317,274 (Direct) | View |
Ownership | 2022-05-26 4:15 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Gilad Oren President | 0 | $0 | 884,678 (Direct) | View |
Ownership | 2022-05-26 4:15 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Duey Marc Director | 0 | $0 | 605,627 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-14 5:03 pm | N/A 2032-03-10 | Aprea Therapeutics Inc. | APRE | SCHADE CHRISTIAN S Chairman & CEO | 527,800 | $0 | 693,816 (Direct) | View |
| 2022-03-10 Tax Withholding | 2022-03-14 5:03 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan SVP, Chief Business Officer | 1,989 | $1.82 | 102,452 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-14 5:03 pm | N/A 2032-03-10 | Aprea Therapeutics Inc. | APRE | Korbel Gregory Alan SVP, Chief Business Officer | 88,600 | $0 | 102,452 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-14 5:02 pm | N/A 2032-03-10 | Aprea Therapeutics Inc. | APRE | Coiante Scott M SVP, Chief Financial Officer | 228,800 | $0 | 305,449 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-14 5:01 pm | N/A 2032-03-10 | Aprea Therapeutics Inc. | APRE | Attar Eyal C. SVP, Chief Medical Officer | 228,800 | $0 | 276,131 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-14 5:01 pm | N/A 2032-03-10 | Aprea Therapeutics Inc. | APRE | Abrahmsen Lars B. SVP, Chief Scientific Officer | 124,700 | $0 | 143,700 (Direct) | View |